A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/30/2006	WO2006126600A1 Pharmaceutical composition for vascular occlusive disease
11/30/2006	WO2006126505A1 Stat function inhibitor and application thereof
11/30/2006	WO2006126199A2 Methods and compositions for treating schizophrenia
11/30/2006	WO2006126198A2 Arts c-terminus fragments and mimetics thereof
11/30/2006	WO2006126188A2 Cxcr4 antagonists for wound healing and re-epithelialization
11/30/2006	WO2006126087A2 Angiotensin i-converting enzyme (ace) inhibitors
11/30/2006	WO2006126025A2 Cytokine
11/30/2006	WO2006125963A2 Modified leukocyte ig-like receptor family members (lir' s) with increased affinity for class i mhc and their uses in modulating t cell activation
11/30/2006	WO2006125930A1 Composition for the treatment of multiple sclerosis
11/30/2006	WO2006125914A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections
11/30/2006	WO2006125868A1 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
11/30/2006	WO2006125867A1 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof
11/30/2006	WO2006125866A1 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
11/30/2006	WO2006125847A1 Production of and antihypertensive properties of peptides derived from egg white proteins
11/30/2006	WO2006125765A2 Acylated insulin with high purity
11/30/2006	WO2006125763A1 Stabilized polypeptide formulations
11/30/2006	WO2006125762A1 Stabilized polypeptide formulations
11/30/2006	WO2006125441A1 Isolated dipeptides with ace inhibitor effect.
11/30/2006	WO2006125322A1 Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
11/30/2006	WO2006125321A1 Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
11/30/2006	WO2006086012A8 Antibiotic compound
11/30/2006	WO2006066323A9 Formulations and treatments for trichology
11/30/2006	WO2006061406A3 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same
11/30/2006	WO2006047799A3 Treatment of heart failure with csf-1
11/30/2006	WO2006042745A3 Chemically modified peptide analogs
11/30/2006	WO2006042197A3 Use of del-1 in hair, bone and cartilage regeneration
11/30/2006	WO2006024275A3 Glp-1 and exendin related invention
11/30/2006	WO2006001931A3 Prouroguanylin as therapeutic and diagnostic agents
11/30/2006	WO2005113811A3 Combinatorial selection of phosphorothioate aptamers for tgf-beta
11/30/2006	WO2005077042A3 Albumin fusion proteins
11/30/2006	WO2005054286A3 Interleukin-11 fusion proteins
11/30/2006	WO2004047728A3 Compositions and methods for the treatment of immune related diseases
11/30/2006	US20060272039 Methods of identifying longevity modulators and therapeutic methods of use thereof
11/30/2006	US20060270839 Crystallization of IGF-1
11/30/2006	US20060270838 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders
11/30/2006	US20060270835 Diagnosis and treatment of Alzheimer disease
11/30/2006	US20060270832 Novel x-conotoxin peptides (-II)
11/30/2006	US20060270831 Novel peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270730 Histone deacetylase inhibitors as immunosuppressants
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270703 G-csf conjugates
11/30/2006	US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha
11/30/2006	US20060270645 Agents and methods for enhancing bone formation
11/30/2006	US20060270624 Gapped 2' modified oligonucleotides
11/30/2006	US20060270619 Polynucleotide used in diagnosis of cell proliferative disease, and as target molecules for developing drugs
11/30/2006	US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
11/30/2006	US20060270609 Inhibitors for the soluble epoxide hydrolase
11/30/2006	US20060270608 Drugs for chronic pain
11/30/2006	US20060270607 Pharmaceutical combinations
11/30/2006	US20060270606 Dolastatin 15 derivatives
11/30/2006	US20060270605 Compositions and methods for inhibiting cell growth and modulating gene expression
11/30/2006	US20060270604 Pharmaceutical preparations of Fn3 polypeptides for human treatments
11/30/2006	US20060270603 Amidated parathyroid hormone fragments and uses thereof
11/30/2006	US20060270602 Mutants of bone morphogenetic proteins
11/30/2006	US20060270601 ARTS C-terminus fragments and mimetics thereof
11/30/2006	US20060270599 Inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity
11/30/2006	US20060270598 treating mammal with an adiponectin mediated disorder by administering a therapeutically effective amount of an adiponectin variant with at least a 3-fold increased solubility relative to residues 110-244 of human adiponectin; to reverse insulin resistance in type II diabetics; vascular atherosclerosis
11/30/2006	US20060270597 Compositions of THAP-family chemokine binding domains
11/30/2006	US20060270596 Compositions of THAP-family chemokine binding domains
11/30/2006	US20060270595 Nucleic acids encoding compositions of THAP-family chemokine binding domains
11/30/2006	US20060270594 Methods and compositions for modulating the HGF/c-met signaling pathway, in particular by inhibiting a hyperstabilized c-met protein; for treating a lung tumor in a subject by administering a c-met antagonist
11/30/2006	US20060270593 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
11/30/2006	US20060270592 Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
11/30/2006	US20060270591 Androgen receptor coregulators
11/30/2006	US20060270590 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
11/30/2006	US20060270589 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of visual disabilities
11/30/2006	US20060270007 Method for producing glucoamylases and their uses
11/30/2006	US20060270003 Nucleotide sequences coding imterleukin-17 polypeptide for use in diagnosis, prevention and treatment of bone, autoimmune, skin and inflammatory disorders
11/30/2006	US20060270002 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270001 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270000 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060269988 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes, and uses thereof
11/30/2006	US20060269976 Method for reducing lysozyme enzymatic activity
11/30/2006	US20060269960 Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269956 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
11/30/2006	US20060269924 Modulation of telomere-initiated cell signaling
11/30/2006	US20060269921 Methods of diagnosis and prognosis of pancreatic cancer
11/30/2006	US20060269918 Compositions, splice variants and methods relating to colon specific genes and proteins
11/30/2006	US20060269917 Compositions, splice variants and methods relating to colon specific gene and proteins
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269892 Methods and systems for enabling and stabilizing tooth movement
11/30/2006	US20060269613 Composition containing nanoparticles containing water-soluble basic drug encpsulated therein
11/30/2006	US20060269590 Enzyme-sensitive therapeutic wound dressings
11/30/2006	US20060269575 Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
11/30/2006	US20060269566 Polypeptide comprising extracellular domain which induces T-cell proliferation response; gene therapy; vaccines; antiproliferative/antitumor agents; cytotoxic T-lymphocyte (CTLA)
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269562 Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereof
11/30/2006	US20060269551 Reducing interleukin (IL-20) induced inflammation by administering antibody, fragment or single chain antibody; adult respiratory disease, psoriasis, eczema, dermatitis, septic shock, multiple organ failure, pneumonia, inflammatory bowel disease, arthritis, asthma, ulcerative colitis, Crohn*s disease
11/30/2006	US20060269549 Tnf-alpha binding molecules
11/30/2006	US20060269548 Lymphatic endothelial cells materials and methods
11/30/2006	US20060269544 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269538 Serine proteases with altered sensitivity to activity-modulating substances
11/30/2006	US20060269537 Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof
11/30/2006	US20060269536 Inhibitor proteins of a protease and use thereof
11/30/2006	US20060269535 Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
11/30/2006	US20060269530 RNA interference compositions and methods
11/30/2006	US20060269525 Co-grafts for treating Parkinson's disease

1 ... 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 ... 3163